SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's starts recall of anti-seizure drug in US market: Report

26 Apr 2019 Evaluate

Dr Reddy's Laboratories has reportedly initiated a voluntary recall of anti-seizure drug Divalproex extended release tablets from the US market owing to cGMP deviations noticed in certain batches of the product.

According to the US Food and Drug Administration (USFDA) report, the company has started recalling of Divalproex 100-count and 500-count bottles, totaling 33,958 bottles on April 11, 2019 after finding out that the product was exposed to humidity levels above 50 percent during packaging.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1235.40 14.15 (1.16%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×